60% of students in the US need to use campus-based funds to pay for their materials . . . DIRECT 2 STUDENT gives them that option at a discount, through their local campus stores.
INDIANPOLIS (PRWEB) January 19, 2021
Willo Labs, the leading technology platform for digital learning delivery, and Elsevier, a global leader in research publishing and information analytics, today announced “DIRECT 2 STUDENT,” a new learning content delivery model combining instant digital learning access with doorstep delivery of print textbooks. The DIRECT 2 STUDENT model is offered exclusively through college campus bookstores, saving stores the cost of shipping and inventory management.
“We joined forces with Willo Labs to transform and modernize how students buy and receive their course materials,” said Jennette Sagraves, Manager, Channel Partners & GTM Strategy at Elsevier. “So many students are learning from home and need a better way to get their books and digital materials. With the Willo Labs technology, we’re giving students instant digital access and shipping their custom print book bundles to the address of their choice.”
“Cost savings and a simple delivery process are what today’s students expect and deserve,” added Kate McKain, President of Willo Labs. “And since 60% of students in the US need to use campus-based funds to pay for their materials, we’re especially proud that DIRECT 2 STUDENT gives them that option at a discount, through their local campus stores.”
The DIRECT 2 STUDENT program is launching at select campuses in January 2021, with full availability starting with Spring 2021 terms. Willo Labs is the distributor of DIRECT 2 STUDENT for US institutions.
About Willo Labs
Willo Labs provides a single connection and platform for colleges, schools and digital materials providers to link and manage digital course materials in the learning management system (LMS). Willo Labs is connected to over 850 campus and school LMSs. Learn more at our website: https://www.willolabs.com/
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.
In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.
Elsevier employs 8,100 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our 2,500+ digitized journals, including The Lancet and Cell; our 40,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. http://www.elsevier.com